U.S. market Closed. Opens in 7 hours 35 minutes

CODX | Co-Diagnostics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue991.47K34.22M97.89M74.55M214.97K39.91K7.66KN/A10.00K
Cost of Revenue5.42M5.48M11.57M16.59M112.43K9.39K302.00N/AN/A
Gross Profit-4.42M28.74M86.31M57.96M102.54K30.52K7.36KN/AN/A
Operating Expenses44.10M40.33M40.25M16.27M6.00M6.15M4.57MN/A1.98M
Selling, General & Admin21.14M21.61M24.95M12.94M4.56M4.74M3.52M919.00K1.13M
Research & Development22.96M17.44M14.96M3.19M1.37M1.36M1.00M731.47K806.91K
Other Operating Expenses22.96M1.28M335.36K138.63K65.90K50.77K45.76KN/A43.14K
Operating Income-48.53M-11.59M46.06M41.69M-5.89M-6.12M-4.56M-1.69M-1.97M
Other Expenses / Income10.42M-7.26M-429.16K875.42K-301.82K-38.76K-2.40M-240.72K-75.19K
Before Tax Income-38.11M-18.85M45.64M42.57M-6.20M-6.27M-6.96M-1.93M-2.04M
Income Tax Expenses-2.78M-4.61M8.98M90.54K-126.44K-18.96KN/AN/AN/A
Net Income-35.33M-14.24M36.66M42.48M-6.07M-6.27M-6.96M-1.93M-2.04M
Interest ExpensesN/A14.88MN/AN/A106.44K134.95K310.23K240.72K75.19K
Basic Shares Outstanding29.35M31.48M28.87M26.72M16.76M12.48M10.96M11.06M11.06M
Diluted Shares Outstanding29.35M31.48M29.90M28.00M16.76M12.48M10.96M11.06M11.18M
EBITDA-47.30M-2.68M46.44M42.71M-6.02M-6.09M-6.60M-1.65M-1.92M
EBITDA Margin-4,770.31%-7.84%47.45%57.29%-2,802.23%-15,248.96%-86,181.69%0.00%-19,248.39%
EBIT-38.11M-3.96M45.64M42.57M-6.09M-6.16M-6.65M-1.69M-1.97M
EBIT Margin-3,843.83%-11.59%46.62%57.10%-2,832.49%-15,423.66%-86,778.90%0.00%-19,679.79%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙